Basis of Presentation and Significant Accounting Policies - Schedule of Revenues consist of product sales to customers (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenues	$ 211,699	$ 130,714	$ 495,396	$ 380,745
NUPLAZID
Disaggregation of Revenue [Line Items]
Total revenues	144,828	130,714	405,308	380,745
DAYBUE
Disaggregation of Revenue [Line Items]
Total revenues	$ 66,871	$ 0	$ 90,088	$ 0